CPC A61M 5/20 (2013.01) [A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/158 (2013.01); A61M 5/24 (2013.01); A61M 5/31501 (2013.01); A61M 5/31568 (2013.01); A61M 5/3202 (2013.01); A61M 5/326 (2013.01); A61M 5/3243 (2013.01); A61M 5/3257 (2013.01); A61M 5/5086 (2013.01); G06Q 50/01 (2013.01); G06Q 50/22 (2013.01); G16H 20/17 (2018.01); G16H 40/00 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61M 2005/3267 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/6009 (2013.01)] | 16 Claims |
1. A drug delivery device comprising:
a housing having an exterior surface;
an opening formed in the exterior surface of the housing;
a reservoir disposed at least partially within the housing;
a delivery member having a proximal end connected or configured to be connected in fluid communication with the reservoir and a distal end configured to extend through the opening in an operative state;
an adhesive disposed at the exterior surface of the housing for releasably attaching the drug delivery device to skin of a patient;
a removable cover coupled with the housing;
an electrical skin contact sensor disposed at the exterior surface of the housing; and
the drug delivery device being configured or programmed to:
(a) determine if the removable cover has been removed from the housing prior to or independent of use of the electrical skin contact sensor for sensing contact with the skin of the patient,
(b) alert the patient if or when the removable cover has been removed from the housing, and
(c) subsequent to (b), alert the patient if or when the drug delivery device has been triggered to deliver a drug to the patient.
|